Author(s):
Rutuja S. Dhaigude, Gurappa K. Dyade, Hrushikesh A. Joshi, Laxmikant M. Purane, Mayuri M. Lakade, Varsha S. Chandgude
Email(s):
pharmacyresearchsvpmcop@gmail.com
DOI:
10.52711/2231-5675.2025.00015 
Address:
Rutuja S. Dhaigude1, Gurappa K. Dyade1, Hrushikesh A. Joshi2, Laxmikant M. Purane3, Mayuri M. Lakade4, Varsha S. Chandgude4
1Dept of Post Graduate in Pharmaceutical Quality Assurance, SVPM’S College of Pharmacy, Malegaon (BKII) Baramati Dist Pune, Maharashtra, India.
2Dept of Post Graduate in Pharmaceutics, SVPM’S College of Pharmacy, Malegaon (BKII) Baramati Dist Pune, Maharashtra, India.
3Dept of Pharmacology, YSPM’S Yashoda Technical Campus - Faculty of Pharmacy, Satara, Maharashtra, India.
4SVPM’S College of Pharmacy, Malegaon (BKII) Baramati Dist Pune, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 15,
Issue - 2,
Year - 2025
ABSTRACT:
The aim of the present research was to develop an absorption spectrophotometric analytical method utilizing economical 0.1 N NaOH solvent for the concurrent estimation of Sitagliptin (SGT) and Glimepiride (GMP). Wavelengths 228nm and 267.5nm were selected for absorbance measurement of GMP and SGT respectively. From the nature of UV spectra simultaneous equation and absorption correction method was found suitable for determination of both drugs. For selection of critical parameters, effect of input variables on spectrum characteristics were studied and developed method was validated as per ICH Q 2 R1 regulatory guidelines. Linearity of the drugs was ascertained over the conc range 20 to 250µg/ml and 1 to 24µg/ml for SGT and GMP respectively. The accuracy was studied and standard deviation 0.0318-3.0515 for SGT and 0.4287-3.4801 for GMP found within acceptable limit; and the assay study data was found 99.54 % for SGT and 95.61 % for GMP. The stability of the method was studied by minor variation in the wavelength, scan speed. The developed method is rigid, robust and efficient for the estimation of SGT and GMP from their respective/combined dosage form. The effort was made to develop sustainable economic analytical method utilising common solvent for drug sitagliptin and water insoluble glimepiride.
Cite this article:
Rutuja S. Dhaigude, Gurappa K. Dyade, Hrushikesh A. Joshi, Laxmikant M. Purane, Mayuri M. Lakade, Varsha S. Chandgude. Absorption Spectrophotometric Method Development for The Simultaneous Estimation of Anti-Diabetic Drugs Sitagliptin and Glimepiride. Asian Journal of Pharmaceutical Analysis. 2025; 15(2):91-8. doi: 10.52711/2231-5675.2025.00015
Cite(Electronic):
Rutuja S. Dhaigude, Gurappa K. Dyade, Hrushikesh A. Joshi, Laxmikant M. Purane, Mayuri M. Lakade, Varsha S. Chandgude. Absorption Spectrophotometric Method Development for The Simultaneous Estimation of Anti-Diabetic Drugs Sitagliptin and Glimepiride. Asian Journal of Pharmaceutical Analysis. 2025; 15(2):91-8. doi: 10.52711/2231-5675.2025.00015 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2025-15-2-4
REFERENCES:
1. The Merck Index, An Encyclopaedia of Chemicals, Drugs and Biological, 15th Edition, the Royal Society of Chemistry Cambridge UK, 2013, pp. 1589,820.
2. Indian Pharmacopoeia, Govt of India, Ministry of Health and Family Welfare, 8th Edition, The Indian Pharmacopoeia Commission Ghaziabad, 2018, II, III: pp. 2177, 3198.
3. Alison Brayfield, Martindale (The complete drug reference), 39th edition, pharmaceutical press London, 2017, A: pp. 481,507.
4. Jain Pritam, Chaudhari Amar, Desai Bhargav, Patel Shani, et al. Development and validation of first order derivative UV-Spectrophotometric method for determination of Sitagliptin phosphate in bulk and in Formulation. International Journal of Drug Development and Research. 2011; 3(4): 194-199.
5. Ravisankar P. Mounika G, Devadasu C, Devalarao G. A simple validated UV spectrophotometric method for quantitative analysis of Sitagliptin Phosphate in Pharmaceutical dosage forms. Journal of Chemical and Pharmaceutical Sciences. 2014; 7(3): 254-258.
6. Disha N S, Gurupadhayya B M. Spectrophotometric determination of Sitagliptin phosphate in bulk and pharmaceutical formulations. International Journal of Innovative science Engineering and Technology. 2015; 2(7): 702-709.
7. Tarkase K N, Sarode M B, Gulve S A, Gawade A. Development and validation of UV spectrophotometric method for estimation of sitagliptin phosphate. Der Pharmacia Lettre. 2013; 5 (3):315-318.
8. Loni Amruta, Ghante Minal, Sawant Sanjay. Simultaneous UV spectrophotometric method for estimation of Sitagliptin phosphate and metformin HCl in bulk and tablet dosage form. Der Pharma Chemical. 2012; 2(8): 854-859.
9. Reichal C, Sangeetha M, Thirumoorthy N. Simultaneous estimation of Gliclazide and Sitagliptin phosphate monohydrate by Q-analysis method. Journal of Chemical and Pharmaceutical Research. 2015; 7(5): 630-635.
10. Khanda F M Amin. Evaluation of greenness and whiteness assessment of chemometric assisted techniques for simultaneous determination of canagliflozin, sitagliptin, metformin, pioglitazone, and glimepiride in a quinary mixture. Sustainable Chemistry and Pharmacy. 2023; 35, doi.org/10.1016/j.scp.2023.101181.
11. Amit S Tapkir, Shital M Biradar, Pravin D Chaudhari. Development And Validation Of Stability Indicating HPTLC Assay Method For Estimation of Sitagliptin Phosphate. International Journal of Pharmaceutical Sciences And Research. 2017; 8 (10): 4454-4460.
12. Jain P S, Chaudhari A J, Surana S J. Development and validation of stability-indicating high-performance thin-layer chromatography method for estimation of sitagliptin phosphate monohydrate in bulk and in pharmaceutical formulation. Acta Chromatographica. 2014; 25(3): 531-544.
13. Patil K R, Deshmukh T A, Patil V R. A Stability Indicating HPTLC Method Development and Validation for Analysis of Sitagliptin as Bulk Drug and in Formulation. American Journal of Pharmtech Research. 2019; 9(6): 123-135.
14. Raja T, Lakshmana Rao A. Validated HPTLC method for simultaneous estimation of Metformin hydrochloride and Sitagliptin phosphate in bulk drug and formulation. Rasayan Journal of Chemistry.2012; 5(5): 407-413.
15. Herman G, Bergman A, Liu F, Stevens C, et al. Pharmacokinetics and pharmacodynamic effects of the oral DPP‐4 inhibitor sitagliptin in middle‐aged obese subjects. Journal of Clinical Pharmacology. 2006; 46(8): 876‐86
16. Sai Lakshmi E, Sravya E, Sireesha D, Bakshi V. Development and Validation of RPHPLC Method for the Estimation of Sitagliptin Phosphate in Tablet Dosage Form. International Journal of Applied Pharmaceutical Sciences and Research. 2017; 2(3):41-45.
17. Pavan Kumar D, Jhansi T N, Rao G S, Jain K. Method Development and Validation for Enantiomer in Sitagliptin Hydrochloride by RP-HPLC. Journal of Chemical and Pharmaceutical Research. 2017; 9(12):13-17.
18. Veronica N, Krishnamoorthy B, Muthukumaran M. Development and validation of a new simple RP-HPLC method for estimation of Metformin HCl and Sitagliptin phosphate simultaneously in bulk and dosage forms. International Journal of Advanced Pharmaceutical Genuine Research. 2014; 2(1): 1-14.
19. Asmaa A El-Zaher, Ehab F Elkady, Hanan M Elwy, Mahmoud A Saleh. Simultaneous determination of metformin, glipizide, repaglinide, and glimepiride or metformin and pioglitazone by a validated LC method: Application in the presence of impurity (1-cyanoguanidine). Journal of AOAC International. 2016; 99 (4): 957-963.
20. Zeng W, Musson D G, Fisher A L, Chen L, Schwartz M S, Woolf E J. Determination of sitagliptin in human urine and hemodialysate using turbulent flow online extraction and tendem mass spectrophotometry. Journal of Pharmaceutical and Biomedical Analysis. 2008; 46(3): 534‐542.
21. Stanislav Bozhanov, Miglena Smerikarova, Vania Maslarska. Simultaneous HPLC determination of remdesivir and dexamethasone in the presence of metformin, sitagliptin, and glimepiride in a synthetic mixture and spiked human plasma. Pharmacia. 2024; 71:1-10.
22. Kjeld Hermansen, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P. Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. Diabetes Obesity and Metabolism. 2007; 9 (5): 733-745.
23. Paul Hartley, Yue Shentu, Patricia Betz-Schiff, Gregory T Golm, Christine McCrary Sisk, Samuel S Engel, R Ravi Shankar. Efficacy and tolerability of sitagliptin compared with glimepiride in elderly patients with type 2 diabetes mellitus and inadequate glycemic control: A randomized, double-blind, non-inferiority trial. Drugs and Aging. 2015; 32: 469-476.
24. Seiya Shimoda, Shinsuke Iwashita, Taiji Sekigami, Noboru Furukawa, Yasuto Matsuo et.al. Comparison of the efficacy of sitagliptin and glimepiride dose‐up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination. Journal of Diabetes Investigation. 2013; 5 (3): 320-326.
25. Yasuo Terauchi, Yuichiro Yamada, Hitoshi Ishida, Mitsuru Ohsugi, Masafumi Kitaoka, Jo Satoh, Daisuke Yabe, Nobuyuki Shihara, Yutaka Seino. Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged≥ 60 years (START‐J trial) Diabetes, Obesity and Metabolism. 2017; 19 (8): 1188-1192.
26. Balamurugan K, Kirtimaya Mishra, Suresh R. Sitagliptin: a literature review on analytical and bio-analytical methods. Pharma Innovation. 2018; 7 (8): 357-361.
27. Arul Caroline Gracea, Thangavel Prabhaa, Murugesan Jagadeeswarana, K Srinivasan, Thangavel Sivakumarb. Analytical methods for determination of sitagliptin: an updated review. International Journal of Pharmaceutical Science Review Research. 2017; 43 (1): 217-225.
28. Sacide Altinoz, Dilara Tekel. Analysis of glimepiride by using derivative UV spectrophotometric method. Journal of Pharmaceutical and Biomedical Analysis. 2001; 24 (3): 507-515.
29. Rudy Bonfilio, Magali B de Araújo, Hérida Salgado. Development and validation of an UV-derivative spectrophotometric method for determination of glimepiride in tablets. Journal of the Brazilian Chemical Society. 2011; 22(2): 292-299.
30. Ozadheoghene E Afieroho, Ogbonna Okorie, Tochukwu J N Okonkwo. An ultraviolet-spectrophotometric method for the determination of glimepiride in solid dosage forms. Diabetes Technology and Therapeutics. 2011; 13 (6): 671-674.
31. Sakala Bhargavi, Gopisetty Suryasagar, Dantu Krishna Sowmya, Kota Ashok, Sreekanth Nama. UV spectrophotometric method for determination of glimepiride in pharmaceutical dosage forms. International Journal of Pharmaceutical Science Review and Research. 2013; 21 (2): 131-133.
32. Rudy Bonfilio, Carolina Peres, Herida R N Salgado, Magali B De Araujo, Cesar R T Tarley. Multivariate development and validation of a stability-indicating HPLC method for the determination of glimepiride in tablets. Journal of AOAC International. 2013; 96 (5): 960-967.
33. Petra Kovarikova, Jiri Klimes, Jiri Dohnal, Lucie Tisovska. HPLC study of glimepiride under hydrolytic stress conditions. Journal of Pharmaceutical and Biomedical Analysis. 2004; 36 (1): 205-209.
34. Abdul Bari Mohd, Krishna Sanka, Rakesh Gullapelly, Prakash V Diwan, Nalini Shastri. (2014). Development and validation of RP-HPLC method for glimepiride and its application for a novel self-nano emulsifying powder (SNEP) formulation analysis and dissolution study. Journal of Analytical Science and Technology. 2014; 5(27): 1-8
35. Abdul Bari Mohd, Krishna Sanka, Rakesh Gullapelly, Prakash V Diwan, Nalini Shastri. Development and validation of RP-HPLC method for glimepiride and its application for a novel self-nanoemulsifying powder (SNEP) formulation analysis and dissolution study. Journal of Analytical Science and Technology. 2014; 5(27): 1-8.
36. Rajendra Narayan Dash, Habibuddin Mohammed, Touseef Humaira. An integrated Taguchi and response surface methodological approach for the optimization of an HPLC method to determine glimepiride in a supersaturatable self-nanoemulsifying formulation. Saudi Pharmaceutical Journal. 2016; 24 (1): 92-103.
37. Khan I U, Aslam F, Ashfaq M, Asghar M N. Determination of glimepiride in pharmaceutical formulations using HPLC and first-derivative spectrophotometric method. Journal of Analytical Chemistry. 2009; 64: 171-175.
38. Sujatha Samala, Sandhya Rani Tatipamula, Ciddi Veeresham. Determination of glimepiride in rat serum by RP-HPLC method. American Journal of Analytical Chemistry. 2011; 2 (2): 152-157.
39. Rita Abi Daoud, Chawki Atallah, Antoine Zoghbi. A simple and sensitive method for determination of glimepiride in human serum by HPLC. Journal of liquid Chromatography and Related Technologies. 2005; 28 (20): 3255-3263.
40. Gulshan Bansal, Manjeet Singh, Jindal K C, Saranjit Singh. LC–UV–PDA and LC–MS studies to characterize degradation products of glimepiride. Journal of Pharmaceutical and Biomedical Analysis. 2008; 48 (3): 788-795.
41. Constantinos Pistos, Maria Koutsopoulou, Irene Panderi. Improved liquid chromatographic tandem mass spectrometric determination and pharmacokinetic study of glimepiride in human plasma. Biomedical Chromatography. 2005; 19 (5): 394-401.
42. Hohyun Kim, Kyu Young Chang, Chang Hun Park, Moon Sun Jang et.al. Determination of glimepiride in human plasma by LC-MS-MS and comparison of sample preparation methods for glimepiride. Chromatographia. 2004; 60: 93-98.
43. N Yuzuak, T Ozden, S Eren, S Ozilhan. Determination of glimepiride in human plasma by LC–MS–MS. Chromatographia. 2007; 66: 165-168.
44. Yun-Kyoung Song, Jeong-Eun Maeng, Hye-Ryung Hwang, Jeong-Sook Park, Bae-Chan Kim, Jin-Ki Kim, Chong-Kook Kim. Determination of glimepiride in human plasma using semi-microbore high performance liquid chromatography with column-switching. Journal of Chromatography B. 2004; 810 (1): 143-149.
45. Lagishetty Chakradhar, Rajareddy Kallem, Arumugam Karthik, Bala Tripura Sundari. et. al. A rapid and highly sensitive method for the determination of glimepiride in human plasma by liquid chromatography–electrospray ionization tandem mass spectrometry: application to a preclinical pharmacokinetic study. Biomedical Chromatography. 2008; 22 (1): 58-63.
46. Isam Ismail Salem, Jafer Idrees, Jaafar I Al Tamimi. Determination of glimepiride in human plasma by liquid chromatography–electrospray ionization tandem mass spectrometry. Journal of Chromatography B. 2004; 799 (1): 103-109.
47. Yannis Dotsikas, Constantinos Kousoulos, Georgia Tsatsou, Yannis L Loukas. Development of a rapid method for the determination of glimepiride in human plasma using liquid‐liquid extraction based on 96‐well format micro‐tubes and liquid chromatography/tandem Mass Spectrometry. Rapid communication Mass Spectrometry. 2005; 19 (14): 2055-2061.
48. Xiaoqin Zhao, Ping Huang, Jie Yuan. Influence of glimepiride plus sitagliptin on treatment outcome, blood glucose, and oxidative stress in diabetic patients. American Journal of Translational Research. 2022; 14 (10): 7459-7466.
49. Subodh Kumar, Anuj Kumar Pathak, Dibyajyoti Saikia, Amish Kumar. Efficacy, safety and treatment satisfaction of glimepiride vs sitagliptin in combination with metformin in type 2 diabetes mellitus. Journal of Clinical and Diagnostic Research: JCDR 2015; 9 (12), FC07.
50. Preeti Singh, Ruchi Choudhary, V K Singh, Prithpal S Matreja. Comparison of metabolic effects of glimepride and sitagliptin with metformin in patients suffering from type 2 diabetes mellitus in a tertiary care hospital. International Journal of Basic Clinical Pharmacology. 2019; 8(7): 1467-1472.
51. Devarajan T V, Venkataraman S, Narayanan Kandasamy, Abraham Oomman, Hari Kishan Boorugu, Karuppiah S K P, Dushyant Balat.Comparative evaluation of safety and efficacy of glimepiride and sitagliptin in combination with metformin in patients with type 2 diabetes mellitus: Indian multicentric randomized trial-start trial. Indian Journal of Endocrinology and Metabolism. 2017; 21 (5): 745-750.
52. Xue Chen, Sheng Kang, Zeqing Bao. Effects of Glimepiride Combined with Recombinant Human Insulin Injection on Serum IGF‐1, VEGF and TRACP‐5b Oxidative Stress Levels in Patients with Type 2 Diabetes Mellitus. Evidence‐Based Complementary and Alternative Medicine. 2022; doi: 10.1155/2022/4718087.
53. British Pharmacopoeia, Medicines and Healthcare products regulatory agency London, 2019, II: 1231.
54. ICH Expert working group. ICH Harmonized tripartite Guideline-Pharmaceutical Quality system Q 10. In current step 4Th version. 2008; p. 1-21.
55. ICH Expert Working Group. ICH Harmonized Tripartite Guideline-Validation of analytical procedures: Text and Methodology Q 2 R1. In current step 4 version. 2005; p. 1-17.
56. Byrne, F.P., Jin, S., Paggiola, G. et al. Tools and techniques for solvent selection: green solvent selection guides. Sustain Chem Process. 2016; 4(7): 1-24. Doi.org/10.1186/s40508-016-0051-z